GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AmCad BioMed 4188.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

14.00

-1.75%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 30.4m

FY2016FY2025

Net income

−TWD 55.7m

FY2016FY2025

Free cash flow

−TWD 47.8m

FY2016FY2025

Shareholders' equity

TWD 521.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 30.4mTWD 53.1mTWD 65.3mTWD 61.6mTWD 85.8mTWD 63.9mTWD 84.1mTWD 72.3mTWD 21.2mTWD 10.1m
Research and developmentTWD 47.1mTWD 43.8mTWD 44.1mTWD 54.0mTWD 50.9mTWD 49.4mTWD 58.3mTWD 67.4mTWD 43.5mTWD 37.6m
Operating income−TWD 88.0m−TWD 64.7m−TWD 43.0m−TWD 54.3m−TWD 26.8m−TWD 42.8m−TWD 56.3m−TWD 80.1m−TWD 64.0m−TWD 59.5m
Net income−TWD 55.7m−TWD 50.6m−TWD 45.3m−TWD 53.5m−TWD 25.5m−TWD 35.4m−TWD 37.7m−TWD 44.7m−TWD 58.6m−TWD 54.6m
Diluted earnings per share-1.01-0.92-0.84-0.97-0.46-0.64-0.71-0.85-1.11-1.16

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 622.7mTWD 694.9mTWD 512.6mTWD 553.9mTWD 615.8m—TWD 734.3mTWD 778.5mTWD 699.7mTWD 756.1m
Cash and short-term investments——————TWD 452.4mTWD 497.1mTWD 607.6mTWD 272.5m
Total liabilitiesTWD 21.9mTWD 31.2mTWD 34.7mTWD 34.1mTWD 36.7m—TWD 201.2mTWD 204.9mTWD 80.3mTWD 78.9m
Debt——————TWD 10.2m———
Shareholders' equityTWD 521.4mTWD 568.7mTWD 380.6mTWD 424.6mTWD 483.0m—TWD 533.1mTWD 573.6mTWD 619.5mTWD 677.2m
Shares outstanding55m55m54m55m55m55m53m53m53m47m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 47.1m−TWD 51.9m−TWD 41.6m−TWD 34.2m−TWD 39.0m−TWD 50.0m—−TWD 69.0m−TWD 48.9mTWD 23.7m
Capital spending−TWD 700,000−TWD 3.0m−TWD 293,000−TWD 614,000−TWD 2.3m−TWD 320,000—−TWD 62.0m−TWD 972,000−TWD 4.2m
Free cash flow−TWD 47.8m−TWD 54.9m−TWD 41.9m−TWD 34.8m−TWD 41.3m−TWD 50.4m—−TWD 131.0m−TWD 49.9mTWD 19.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 6.7mTWD 6.4mTWD 5.1mTWD 10.4mTWD 8.2mTWD 6.8mTWD 18.1mTWD 10.5m
Operating income−TWD 22.5m−TWD 18.3m−TWD 26.3m−TWD 19.5m−TWD 20.8m−TWD 21.3m−TWD 10.1m−TWD 22.1m
Net income−TWD 15.1m−TWD 13.5m−TWD 14.1m−TWD 10.0m−TWD 16.1m−TWD 15.6m−TWD 6.8m−TWD 17.9m
Diluted earnings per share-0.27-0.25-0.26-0.18-0.29-0.28-0.12-0.33
Cash from operations−TWD 13.0m−TWD 14.0m−TWD 15.0m−TWD 3.0m−TWD 12.0m−TWD 14.0m−TWD 10.0m−TWD 13.0m
Capital spending———————−TWD 2.0m
Free cash flow———————−TWD 15.0m
Total assetsTWD 617.4mTWD 606.1mTWD 622.7mTWD 639.1mTWD 641.3mTWD 662.8mTWD 694.9mTWD 698.6m
Shareholders' equityTWD 515.5mTWD 502.5mTWD 521.4mTWD 525.1mTWD 532.1mTWD 548.1mTWD 568.7mTWD 575.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-21.0%-13.8%71.2%
Operating income17.5%15.5%3.2%
Net income1.4%9.5%-1.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-182.7%-118.8%-88.7%-117.4%
Net margin-127.2%-97.5%-73.9%-95.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-14.5-24.4-31.6-16.4-41.7-30.0-34.0-32.3-25.2-26.3
Price to sales26.623.221.914.312.416.615.320.069.6141.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.